High Incidence of Human Herpes Virus 6-Associated Encephalitis/Myelitis following a Second Unrelated Cord Blood Transplantation

Yasuo Mori, Toshihiro Miyamoto, Koji Nagafuji, Kenjiro Kamezaki, Asataro Yamamoto, Noriyuki Saito, Koji Kato, Katsuto Takenaka, Hiromi Iwasaki, Naoki Harada, Yasunobu Abe, Takanori Teshima, Koichi Akashi

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Human herpes virus (HHV)6-associated limbic encephalitis and/or myelitis is one of the life-threatening central nervous system complications following allogeneic hematopoietic stem cell transplantation (HSCT). Recent reports have shown significant correlations of these complications with unrelated cord blood transplantation (UCBT). We retrospectively analyzed 228 allogeneic HSCT recipients in our single institution; 13 patients (5.7%) were diagnosed with HHV6-associated encephalitis/myelitis. This complication was documented in 8 of 51 UCBT recipients (15.7%) and 5 of 177 recipients (2.8%) transplanted with bone marrow or peripheral blood stem cells, indicating a higher incidence of this complication occurring in UCBT recipients (P =0005). In addition, HHV6-associated encephalitis/myelitis occurred more frequently in recipients who underwent 2 or more HSCTs (7 of 59 recipients [11.9%]), compared to those who received only 1 HSCT (6 of 169 recipients [3.6%], P =018). Of note, the incidence of this complication increased to 28.6% (6 of 21 recipients), when the analysis was restricted to a second or more UCBT recipients. All 13 patients presented preengraftment immune response prior to the onset of encephalitis. Two patients manifested typical symptoms at the onset of HHV6-associated encephalitis/myelitis, such as memory dysfunction, disorientation, and consciousness disturbance. However, 4 patients presented only with dysesthesia and pruritus, described as typical manifestations of patients with calcineurin-inhibitor-induced pain syndrome (CIPS), and the remaining 7 showed both symptoms, indicating that CIPS-like symptoms might be manifestations of HHV6-associated myelitis. Thus, physicians should be alert to this rare but often fatal complication, particularly for those who receive 2 or more HSCTs using UCB.

Original languageEnglish
Pages (from-to)1596-1602
Number of pages7
JournalBiology of Blood and Marrow Transplantation
Volume16
Issue number11
DOIs
Publication statusPublished - Nov 1 2010

Fingerprint

Myelitis
Human Herpesvirus 6
Encephalitis
Fetal Blood
Transplantation
Viruses
Hematopoietic Stem Cell Transplantation
Incidence
Limbic Encephalitis
Pain
Confusion
Paresthesia
Pruritus
Consciousness
Central Nervous System
Bone Marrow
Physicians

All Science Journal Classification (ASJC) codes

  • Hematology
  • Transplantation

Cite this

High Incidence of Human Herpes Virus 6-Associated Encephalitis/Myelitis following a Second Unrelated Cord Blood Transplantation. / Mori, Yasuo; Miyamoto, Toshihiro; Nagafuji, Koji; Kamezaki, Kenjiro; Yamamoto, Asataro; Saito, Noriyuki; Kato, Koji; Takenaka, Katsuto; Iwasaki, Hiromi; Harada, Naoki; Abe, Yasunobu; Teshima, Takanori; Akashi, Koichi.

In: Biology of Blood and Marrow Transplantation, Vol. 16, No. 11, 01.11.2010, p. 1596-1602.

Research output: Contribution to journalArticle

Mori, Yasuo ; Miyamoto, Toshihiro ; Nagafuji, Koji ; Kamezaki, Kenjiro ; Yamamoto, Asataro ; Saito, Noriyuki ; Kato, Koji ; Takenaka, Katsuto ; Iwasaki, Hiromi ; Harada, Naoki ; Abe, Yasunobu ; Teshima, Takanori ; Akashi, Koichi. / High Incidence of Human Herpes Virus 6-Associated Encephalitis/Myelitis following a Second Unrelated Cord Blood Transplantation. In: Biology of Blood and Marrow Transplantation. 2010 ; Vol. 16, No. 11. pp. 1596-1602.
@article{552eb359872c46db91967bed5a3b70ff,
title = "High Incidence of Human Herpes Virus 6-Associated Encephalitis/Myelitis following a Second Unrelated Cord Blood Transplantation",
abstract = "Human herpes virus (HHV)6-associated limbic encephalitis and/or myelitis is one of the life-threatening central nervous system complications following allogeneic hematopoietic stem cell transplantation (HSCT). Recent reports have shown significant correlations of these complications with unrelated cord blood transplantation (UCBT). We retrospectively analyzed 228 allogeneic HSCT recipients in our single institution; 13 patients (5.7{\%}) were diagnosed with HHV6-associated encephalitis/myelitis. This complication was documented in 8 of 51 UCBT recipients (15.7{\%}) and 5 of 177 recipients (2.8{\%}) transplanted with bone marrow or peripheral blood stem cells, indicating a higher incidence of this complication occurring in UCBT recipients (P =0005). In addition, HHV6-associated encephalitis/myelitis occurred more frequently in recipients who underwent 2 or more HSCTs (7 of 59 recipients [11.9{\%}]), compared to those who received only 1 HSCT (6 of 169 recipients [3.6{\%}], P =018). Of note, the incidence of this complication increased to 28.6{\%} (6 of 21 recipients), when the analysis was restricted to a second or more UCBT recipients. All 13 patients presented preengraftment immune response prior to the onset of encephalitis. Two patients manifested typical symptoms at the onset of HHV6-associated encephalitis/myelitis, such as memory dysfunction, disorientation, and consciousness disturbance. However, 4 patients presented only with dysesthesia and pruritus, described as typical manifestations of patients with calcineurin-inhibitor-induced pain syndrome (CIPS), and the remaining 7 showed both symptoms, indicating that CIPS-like symptoms might be manifestations of HHV6-associated myelitis. Thus, physicians should be alert to this rare but often fatal complication, particularly for those who receive 2 or more HSCTs using UCB.",
author = "Yasuo Mori and Toshihiro Miyamoto and Koji Nagafuji and Kenjiro Kamezaki and Asataro Yamamoto and Noriyuki Saito and Koji Kato and Katsuto Takenaka and Hiromi Iwasaki and Naoki Harada and Yasunobu Abe and Takanori Teshima and Koichi Akashi",
year = "2010",
month = "11",
day = "1",
doi = "10.1016/j.bbmt.2010.05.009",
language = "English",
volume = "16",
pages = "1596--1602",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - High Incidence of Human Herpes Virus 6-Associated Encephalitis/Myelitis following a Second Unrelated Cord Blood Transplantation

AU - Mori, Yasuo

AU - Miyamoto, Toshihiro

AU - Nagafuji, Koji

AU - Kamezaki, Kenjiro

AU - Yamamoto, Asataro

AU - Saito, Noriyuki

AU - Kato, Koji

AU - Takenaka, Katsuto

AU - Iwasaki, Hiromi

AU - Harada, Naoki

AU - Abe, Yasunobu

AU - Teshima, Takanori

AU - Akashi, Koichi

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Human herpes virus (HHV)6-associated limbic encephalitis and/or myelitis is one of the life-threatening central nervous system complications following allogeneic hematopoietic stem cell transplantation (HSCT). Recent reports have shown significant correlations of these complications with unrelated cord blood transplantation (UCBT). We retrospectively analyzed 228 allogeneic HSCT recipients in our single institution; 13 patients (5.7%) were diagnosed with HHV6-associated encephalitis/myelitis. This complication was documented in 8 of 51 UCBT recipients (15.7%) and 5 of 177 recipients (2.8%) transplanted with bone marrow or peripheral blood stem cells, indicating a higher incidence of this complication occurring in UCBT recipients (P =0005). In addition, HHV6-associated encephalitis/myelitis occurred more frequently in recipients who underwent 2 or more HSCTs (7 of 59 recipients [11.9%]), compared to those who received only 1 HSCT (6 of 169 recipients [3.6%], P =018). Of note, the incidence of this complication increased to 28.6% (6 of 21 recipients), when the analysis was restricted to a second or more UCBT recipients. All 13 patients presented preengraftment immune response prior to the onset of encephalitis. Two patients manifested typical symptoms at the onset of HHV6-associated encephalitis/myelitis, such as memory dysfunction, disorientation, and consciousness disturbance. However, 4 patients presented only with dysesthesia and pruritus, described as typical manifestations of patients with calcineurin-inhibitor-induced pain syndrome (CIPS), and the remaining 7 showed both symptoms, indicating that CIPS-like symptoms might be manifestations of HHV6-associated myelitis. Thus, physicians should be alert to this rare but often fatal complication, particularly for those who receive 2 or more HSCTs using UCB.

AB - Human herpes virus (HHV)6-associated limbic encephalitis and/or myelitis is one of the life-threatening central nervous system complications following allogeneic hematopoietic stem cell transplantation (HSCT). Recent reports have shown significant correlations of these complications with unrelated cord blood transplantation (UCBT). We retrospectively analyzed 228 allogeneic HSCT recipients in our single institution; 13 patients (5.7%) were diagnosed with HHV6-associated encephalitis/myelitis. This complication was documented in 8 of 51 UCBT recipients (15.7%) and 5 of 177 recipients (2.8%) transplanted with bone marrow or peripheral blood stem cells, indicating a higher incidence of this complication occurring in UCBT recipients (P =0005). In addition, HHV6-associated encephalitis/myelitis occurred more frequently in recipients who underwent 2 or more HSCTs (7 of 59 recipients [11.9%]), compared to those who received only 1 HSCT (6 of 169 recipients [3.6%], P =018). Of note, the incidence of this complication increased to 28.6% (6 of 21 recipients), when the analysis was restricted to a second or more UCBT recipients. All 13 patients presented preengraftment immune response prior to the onset of encephalitis. Two patients manifested typical symptoms at the onset of HHV6-associated encephalitis/myelitis, such as memory dysfunction, disorientation, and consciousness disturbance. However, 4 patients presented only with dysesthesia and pruritus, described as typical manifestations of patients with calcineurin-inhibitor-induced pain syndrome (CIPS), and the remaining 7 showed both symptoms, indicating that CIPS-like symptoms might be manifestations of HHV6-associated myelitis. Thus, physicians should be alert to this rare but often fatal complication, particularly for those who receive 2 or more HSCTs using UCB.

UR - http://www.scopus.com/inward/record.url?scp=77957750045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957750045&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2010.05.009

DO - 10.1016/j.bbmt.2010.05.009

M3 - Article

C2 - 20685258

AN - SCOPUS:77957750045

VL - 16

SP - 1596

EP - 1602

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 11

ER -